US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist

9.240
+0.300+3.36%

Close Nov 6 16:00 ET

513.68MMarket Cap-4994P/E (TTM)

Foghorn Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-55.33%7.81M

23.02%6.89M

-4.88%5.05M

77.63%34.16M

37.88%5.77M

163.46%17.48M

24.70%5.6M

35.43%5.31M

1,357.77%19.23M

486.82%4.18M

Operating revenue

-55.33%7.81M

23.02%6.89M

-4.88%5.05M

77.63%34.16M

37.88%5.77M

163.46%17.48M

24.70%5.6M

35.43%5.31M

1,357.77%19.23M

486.82%4.18M

Cost of revenue

Gross profit

Operating expense

-8.39%31.66M

-17.34%31.12M

-13.93%33.24M

4.18%142.06M

-13.43%31.23M

-0.96%34.56M

11.79%37.65M

21.76%38.63M

33.62%136.37M

25.26%36.07M

Selling and administrative expenses

-16.09%6.97M

-12.81%7.33M

-10.77%7.71M

5.29%32.37M

-10.68%7.02M

4.31%8.31M

9.05%8.4M

19.75%8.64M

41.51%30.75M

24.16%7.86M

-General and administrative expense

-16.09%6.97M

-12.81%7.33M

-10.77%7.71M

5.29%32.37M

-10.68%7.02M

4.31%8.31M

9.05%8.4M

19.75%8.64M

41.51%30.75M

24.16%7.86M

Research and development costs

-5.95%24.69M

-18.64%23.8M

-14.84%25.53M

3.85%109.69M

-14.19%24.21M

-2.51%26.25M

12.60%29.25M

22.35%29.99M

31.49%105.62M

25.58%28.21M

Operating profit

-39.64%-23.85M

24.39%-24.23M

15.38%-28.19M

7.88%-107.91M

20.16%-25.46M

39.56%-17.08M

-9.81%-32.05M

-19.83%-33.32M

-16.28%-117.14M

-13.55%-31.89M

Net non-operating interest income expense

26.95%3.5M

2.76%2.87M

-8.62%2.44M

91.63%10.88M

11.95%2.66M

49.70%2.75M

128.00%2.79M

1,035.74%2.67M

407.26%5.68M

202.33%2.38M

Non-operating interest income

26.95%3.5M

2.76%2.87M

-8.62%2.44M

91.63%10.88M

11.95%2.66M

49.70%2.75M

128.00%2.79M

1,035.74%2.67M

9,518.64%5.68M

225.32%2.38M

Other net income (expense)

71.29%1.24M

-326.83%-1.62M

2.64%739K

9.73%2.83M

8.65%678K

10.75%721K

9.54%712K

9.92%720K

104.60%2.58M

624K

Special income (charges)

--0

---2.4M

----

--0

----

-Less:Impairment of capital assets

--0

--2.4M

----

--0

----

Other non- operating income (expenses)

71.29%1.24M

9.97%783K

2.64%739K

9.73%2.83M

8.65%678K

10.75%721K

9.54%712K

9.92%720K

3.45%2.58M

--624K

Income before tax

-40.53%-19.12M

19.50%-22.98M

16.41%-25.02M

13.48%-94.2M

23.42%-22.12M

47.20%-13.61M

-4.51%-28.55M

-11.20%-29.93M

-7.46%-108.88M

0.88%-28.89M

Income tax

4.23M

1.99M

738K

942K

560K

Net income

-33.30%-19.12M

22.07%-22.98M

17.95%-25.02M

9.60%-98.43M

16.55%-24.11M

44.33%-14.35M

-7.96%-29.49M

-13.28%-30.49M

-7.46%-108.88M

0.88%-28.89M

Net income continuous Operations

-33.30%-19.12M

22.07%-22.98M

17.95%-25.02M

9.60%-98.43M

16.55%-24.11M

44.33%-14.35M

-7.96%-29.49M

-13.28%-30.49M

-7.46%-108.88M

0.88%-28.89M

Minority interest income

Net income attributable to the parent company

-33.30%-19.12M

22.07%-22.98M

17.95%-25.02M

9.60%-98.43M

16.55%-24.11M

44.33%-14.35M

-7.96%-29.49M

-13.28%-30.49M

-7.46%-108.88M

0.88%-28.89M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-33.30%-19.12M

22.07%-22.98M

17.95%-25.02M

9.60%-98.43M

16.55%-24.11M

44.33%-14.35M

-7.96%-29.49M

-13.28%-30.49M

-7.46%-108.88M

0.88%-28.89M

Basic earnings per share

8.82%-0.31

35.71%-0.45

19.18%-0.59

10.69%-2.34

17.39%-0.57

45.16%-0.34

-6.06%-0.7

-12.31%-0.73

4.03%-2.62

10.39%-0.69

Diluted earnings per share

8.82%-0.31

35.71%-0.45

19.18%-0.59

10.69%-2.34

17.39%-0.57

45.16%-0.34

-6.06%-0.7

-12.31%-0.73

4.03%-2.62

10.39%-0.69

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-55.33%7.81M	23.02%6.89M	-4.88%5.05M	77.63%34.16M	37.88%5.77M	163.46%17.48M	24.70%5.6M	35.43%5.31M	1,357.77%19.23M	486.82%4.18M
Operating revenue	-55.33%7.81M	23.02%6.89M	-4.88%5.05M	77.63%34.16M	37.88%5.77M	163.46%17.48M	24.70%5.6M	35.43%5.31M	1,357.77%19.23M	486.82%4.18M
Cost of revenue
Gross profit
Operating expense	-8.39%31.66M	-17.34%31.12M	-13.93%33.24M	4.18%142.06M	-13.43%31.23M	-0.96%34.56M	11.79%37.65M	21.76%38.63M	33.62%136.37M	25.26%36.07M
Selling and administrative expenses	-16.09%6.97M	-12.81%7.33M	-10.77%7.71M	5.29%32.37M	-10.68%7.02M	4.31%8.31M	9.05%8.4M	19.75%8.64M	41.51%30.75M	24.16%7.86M
-General and administrative expense	-16.09%6.97M	-12.81%7.33M	-10.77%7.71M	5.29%32.37M	-10.68%7.02M	4.31%8.31M	9.05%8.4M	19.75%8.64M	41.51%30.75M	24.16%7.86M
Research and development costs	-5.95%24.69M	-18.64%23.8M	-14.84%25.53M	3.85%109.69M	-14.19%24.21M	-2.51%26.25M	12.60%29.25M	22.35%29.99M	31.49%105.62M	25.58%28.21M
Operating profit	-39.64%-23.85M	24.39%-24.23M	15.38%-28.19M	7.88%-107.91M	20.16%-25.46M	39.56%-17.08M	-9.81%-32.05M	-19.83%-33.32M	-16.28%-117.14M	-13.55%-31.89M
Net non-operating interest income expense	26.95%3.5M	2.76%2.87M	-8.62%2.44M	91.63%10.88M	11.95%2.66M	49.70%2.75M	128.00%2.79M	1,035.74%2.67M	407.26%5.68M	202.33%2.38M
Non-operating interest income	26.95%3.5M	2.76%2.87M	-8.62%2.44M	91.63%10.88M	11.95%2.66M	49.70%2.75M	128.00%2.79M	1,035.74%2.67M	9,518.64%5.68M	225.32%2.38M
Other net income (expense)	71.29%1.24M	-326.83%-1.62M	2.64%739K	9.73%2.83M	8.65%678K	10.75%721K	9.54%712K	9.92%720K	104.60%2.58M	624K
Special income (charges)	--0	---2.4M	----	----	----	--0	--0	----	----	----
-Less:Impairment of capital assets	--0	--2.4M	----	----	----	--0	--0	----	----	----
Other non- operating income (expenses)	71.29%1.24M	9.97%783K	2.64%739K	9.73%2.83M	8.65%678K	10.75%721K	9.54%712K	9.92%720K	3.45%2.58M	--624K
Income before tax	-40.53%-19.12M	19.50%-22.98M	16.41%-25.02M	13.48%-94.2M	23.42%-22.12M	47.20%-13.61M	-4.51%-28.55M	-11.20%-29.93M	-7.46%-108.88M	0.88%-28.89M
Income tax	0	0	0	4.23M	1.99M	738K	942K	560K	0	0
Net income	-33.30%-19.12M	22.07%-22.98M	17.95%-25.02M	9.60%-98.43M	16.55%-24.11M	44.33%-14.35M	-7.96%-29.49M	-13.28%-30.49M	-7.46%-108.88M	0.88%-28.89M
Net income continuous Operations	-33.30%-19.12M	22.07%-22.98M	17.95%-25.02M	9.60%-98.43M	16.55%-24.11M	44.33%-14.35M	-7.96%-29.49M	-13.28%-30.49M	-7.46%-108.88M	0.88%-28.89M
Minority interest income
Net income attributable to the parent company	-33.30%-19.12M	22.07%-22.98M	17.95%-25.02M	9.60%-98.43M	16.55%-24.11M	44.33%-14.35M	-7.96%-29.49M	-13.28%-30.49M	-7.46%-108.88M	0.88%-28.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-33.30%-19.12M	22.07%-22.98M	17.95%-25.02M	9.60%-98.43M	16.55%-24.11M	44.33%-14.35M	-7.96%-29.49M	-13.28%-30.49M	-7.46%-108.88M	0.88%-28.89M
Basic earnings per share	8.82%-0.31	35.71%-0.45	19.18%-0.59	10.69%-2.34	17.39%-0.57	45.16%-0.34	-6.06%-0.7	-12.31%-0.73	4.03%-2.62	10.39%-0.69
Diluted earnings per share	8.82%-0.31	35.71%-0.45	19.18%-0.59	10.69%-2.34	17.39%-0.57	45.16%-0.34	-6.06%-0.7	-12.31%-0.73	4.03%-2.62	10.39%-0.69
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data